XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 27, 2025
Sep. 28, 2024
Cash flows from operating activities:    
Net loss $ (4,199,562) $ (41,930,555)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 639,292 470,627
Stock-based compensation 2,627,857 2,624,292
Loss on disposal of property and equipment 38,500
Investment impairment net of unrealized gains 472,000 1,787,852
Gain on sale of equity investment (300,000)
Income taxes 156,684 125,000
Foreign currency (gains) losses 31,349 (133,002)
Provision for credit losses 24,000
Noncash provision for excess inventory 925,402 1,502,468
Accrued litigation damages (5,100,000) 24,800,000
Changes in assets and liabilities:    
Accounts receivable 5,215,946 1,031,331
Contract assets (2,874,195) (5,074,336)
Inventory (1,013,049) (390,427)
Prepaid expenses, other current assets and other assets (1,809,006) (426,901)
Accounts payable and accrued expenses (3,281,928) 3,106,567
Accrued warranty (487,717) 514,321
Contract liabilities 1,275,224 (671,790)
Net cash used in operating activities (7,683,203) (12,640,553)
Cash flows from investing activities:    
Capital expenditures (1,340,364) (320,873)
Purchases of marketable securities (15,156,585) (16,875,308)
Proceeds from sale of marketable securities 36,380,280 6,915,102
Proceeds from sale of equity investment 300,000
Other assets 122 (152,971)
Net cash from (used in) investing activities 20,183,453 (10,434,050)
Cash flows from financing activities:    
Issuance of common stock and pre-funded warrants, net of costs 32,439,631
Payments of issuance costs (40,000)
Settlements of restricted stock for tax withholding obligations (114,706)
Net cash (used in) provided by financing activities (154,706) 32,439,631
Effect of exchange rate changes on cash 2,476 4,880
Net increase in cash, cash equivalents and restricted cash 12,348,020 9,369,908
Cash, cash equivalents and restricted cash:    
Beginning of period 15,210,120 6,210,685
End of period 27,558,140 15,580,593
Supplemental disclosure of cash flow information:    
Unpaid equity issuance costs 560,000
Unpaid letter of credit debt issuance costs $ 460,000